Recent progress in cancer care continue to present promise for patients. Scientists are diligently exploring novel approaches, including immune therapies , targeted agents, and precision approaches. A key finding published this week demonstrates the potential of a experimental drug in combating late-stage NSCLC. Furthermore, continued trials are ce